Related Experiment Video
Updated: Apr 8, 2026

Isolation and Culture of Pulmonary Endothelial Cells from Neonatal Mice
Published on: December 14, 2010
Diversity of Rhinovirus and Enterovirus Infections Among Pediatric Patients Hospitalized in Wisconsin, 2022-2023
Hannah L Litwak1, Carlos M Perez1, Allen Bateman2
1Wisconsin Division of Public Health, Wisconsin Department of Health Services, Madison, Wisconsin, USA.
Insights
Severe pediatric respiratory infections from rhinovirus (RV) and enterovirus (EV) rose in 2022-2023. RV-A and RV-C were key contributors in Wisconsin, highlighting the need for year-round molecular surveillance of these viral types.
Area of Science:
- Virology
- Pediatric Infectious Diseases
- Molecular Epidemiology
Background:
- Severe respiratory infections in children caused by rhinovirus (RV) and enterovirus (EV) saw an increase in the US during the 2022-2023 period.
- Understanding the genetic diversity and clinical impact of these viruses is crucial for public health strategies.
Purpose of the Study:
- To characterize the genetic diversity of RV/EV in hospitalized children in Wisconsin.
- To describe the demographic and clinical factors associated with different RV/EV types.
Main Methods:
- Viral typing of submitted specimens using partial VP4/VP2 (RV) and VP1 (EV) gene sequencing.
- Abstraction of patient demographic, comorbidity, and hospitalization data from medical records.
Main Results:
- Rhinovirus-C (RV-C) and Rhinovirus-A (RV-A) were the most prevalent species, identified in 42% and 32% of cases, respectively.
- Forty-six RV types and 5 EV types were identified.
- Children with RV-C infections had a higher prevalence of asthma (30%) compared to other RV infections (9%).
Conclusions:
- RV-A and RV-C were significant causes of severe pediatric respiratory illness in Wisconsin.
- Molecular typing revealed expected viral divergence, but year-round characterization is necessary for comprehensive understanding.
Abstract:
Severe rhinovirus (RV)/enterovirus (EV) respiratory infections in pediatric patients increased in the US during 2022-2023. This study aimed to characterize RV/EV genetic diversity among hospitalized children in Wisconsin and describe demographic and clinical factors of patients by RV/EV type. During September 2022-April 2023, five Wisconsin pediatric hospitals submitted five RV/EV-positive specimens weekly to CDC. Viral typing was performed using partial viral protein (VP) 4/VP2 (RV) and VP1 (EV) sequencing. Wisconsin Department of Health Services abstracted demographic, comorbid condition, and hospitalization course information from patient medical records. Ninety-six patients were included in this investigation. RV-C (n = 40, 42%) and RV-A (n = 31, 32%) were the most frequently detected species, with 46 RV and 5 EV types identified. The median age was 2.5 (IQR: 0.7-5.5) years. Seventy-one (74%) children had at least one comorbid condition. Asthma was more common among children with RV-C infections (n = 12, 30%) compared with other RVs (n = 3, 9%) (p = 0.02). RV-A and RV-C were important contributors to severe pediatric respiratory infection in Wisconsin. Molecular typing showed virus divergence typically observed during season-long investigations. Year-round molecular characterization is needed to better understand the contribution of RV/EV types to severe pediatric respiratory illness.
Related Concept Videos
Viral Recombination
Bacterial Gastroenteritis
Viral Meningitis
Influenza

